Prestige Consumer Healthcare (PBH)

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Prestige Consumer Healthcare Inc	-43.2	0%	-5%	3.2	0.8
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

November 6, 2022 - AI Summary

Q2 revenues of $289 million, up 5% organically compared to the prior year.

Strong sales performance driven by the International segment and the Hydralyte brand.

E-commerce business grew 15% in the first half of the year, outpacing other non-healthcare categories.

$174.97

146% upside

Undervalued by 146% based on the discounted cash flow analysis.

P/E Ratio	-43.17
PEG	-2048.05
Price to Sales	3.23
Price to Book Ratio	2.22
Enterprise Value to Revenue	4.07
Enterprise Value to EBIT	13.22
Enterprise Value to Net Income	-58
Total Debt to Enterprise	0.26
Debt to Equity	0.75

Prestige Consumer Healthcare Inc